Grant: Master's Award: Canada Graduate Scholarships
University of Alberta
$17,500.00
Understanding the role of microglia to neurotoxicity in multiple sclerosis
FY 2023-24
Summary
Multiple sclerosis (MS) is a chronic, debilitating condition affecting 1 in 400 Canadians, one of the highest rates in the world. MS is caused by the loss of a fatty covering that surrounds nerves - the wires of the brain. Loss of this fatty covering, known as myelin, impairs communication between the brain and the body. This often results in disability and impaired quality of life for people living with MS. Current treatments are limited for slowing the progression of MS.
Death of myelin-producing cells and myelin loss are key pathological processes in MS and are associated with the brain's immune cells, called microglia. The role of microglia in MS is not well understood; in some situations, they are protective and in others, they are toxic. Understanding how microglia induce toxicity is key to developing targeted therapies to alleviate disability in MS. We aim to use a mouse model of MS to understand microglial-induced damage to myelin. How microglia change throughout MS progression is unknown, but may involve a group of microglia that release inflammatory molecules, as in other neurodegenerative conditions. We hypothesize that the death of myelin-producing cells leads to the release of factors by microglia that perpetuate a cycle of cell death, inflammation, and demyelination. Such a cycle could provide a new therapeutic target for MS treatment. Effective treatments offer the potential to greatly improve the quality of life for the many people living with MS.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
506244
Name
Souter Katherine M
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Understanding the role of microglia to neurotoxicity in multiple sclerosis
Programtype2
Studentship Programs
Orgnameinp2
University of Alberta
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Confocal Imaging; Cuprizone; Demyelination; Immunohistochemistry; Microglia; Multiple Sclerosis; Neuroimmunology; Neuroinflammation; Neuroscience; Remyelination
Abstract
Multiple sclerosis (MS) is a chronic, debilitating condition affecting 1 in 400 Canadians, one of the highest rates in the world. MS is caused by the loss of a fatty covering that surrounds nerves - the wires of the brain. Loss of this fatty covering, known as myelin, impairs communication between the brain and the body. This often results in disability and impaired quality of life for people living with MS. Current treatments are limited for slowing the progression of MS.
Death of myelin-producing cells and myelin loss are key pathological processes in MS and are associated with the brain's immune cells, called microglia. The role of microglia in MS is not well understood; in some situations, they are protective and in others, they are toxic. Understanding how microglia induce toxicity is key to developing targeted therapies to alleviate disability in MS. We aim to use a mouse model of MS to understand microglial-induced damage to myelin. How microglia change throughout MS progression is unknown, but may involve a group of microglia that release inflammatory molecules, as in other neurodegenerative conditions. We hypothesize that the death of myelin-producing cells leads to the release of factors by microglia that perpetuate a cycle of cell death, inflammation, and demyelination. Such a cycle could provide a new therapeutic target for MS treatment. Effective treatments offer the potential to greatly improve the quality of life for the many people living with MS.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Souter, Katherine M
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~